Summary
The improved survival of cystic fibrosis (CF) patients is partly due to intensive treatment for their chronic infections. Treatment usually includes intravenous and nebulised aminoglycoside antibiotics and they receive a large cumulative dose of these antibiotics over their lifetime. There is little information in the literature on the prevalence of ototoxicity due to aminoglycoside in these patients.
We performed pure tone auditometry on 43 CF patients aged 14–42 years. Seven (16%) had bilateral sensorineural hearing loss (SNHL) for high frequency sounds, consistent with aminoglycoside induced ototoxicity. However, only 2 of these patients had documented toxic serum levels in the past.
The identification of bilateral SNHL in one in six adult CF patients is a cause for concern. It may be that the high cumulative dose of aminoglycosides received by these patients may be causing inner ear injury in the absence of specific episodes of toxic serum levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
De Arce, M. Mulherin, D., McWilliams, P., Lawler, M., FitzGerald, M. X., Humphries, P. Frequency of deletion 508 among Irish cystic fibrosis patients. Hum. Gen. 1990: 85, 403–404.
Nevin, G. B., Nevin, N. C., Redmond, A. O. Prevalence and survival of patients with cystic fibrosis in Northern Ireland, 1961-1971. Ulster Med. J. 1983: 52, 153–156.
Gibson, L. E., Cooke, R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilising pilocarpine by iontophoresis. Pediatrics 1959: 23, 545–549.
Phelan, P. D., Hey, E. Cystic fibrosis mortality in England and Wales and in Victoria, Australia 1976-1980. Arch. Dis. Child. 1984: 59, 71–73.
Corey, M. L. Longitudinal studies in cystic fibrosis. In: Perspectives in Cystic Fibrosis, Sturgess, J. M. (ed.). Proceedings of the 8th International CF Congress, Toronto, Canada. Canadian CF Foundation. Toronto: 1980: 246–255.
Neilsen, O. H., Schiotz, P. O. Cystic fibrosis in Denmark in the period 1945-1981. Evaluation of centralised treatment. Acta Paediatr. Scand. [Supp.] 1982: 301, 107–119.
Penketh, A. R. L., Wise, A., Meams, M. B., Hodson, M. E., Batten, J. C. Cystic fibrosis in adolescents and adults. Thorax. 1987: 42, 526–532.
Keams, G. L., Hilman, B. C., Wilson, J. T. Dosing implications of altered gentamicin desposition in patients with cystic fibrosis. J. Pediatr. 1982: 100, 312–218.
Kelly, H. B., Menendez, R., Leland, F., Murphy, S. Pharmacokinetics of tobramycin in cystic fibrosis. J. Pediatr. 1982: 100, 318–321.
Buring, J. E., Evans, D. A., Mayrent, S. L., Rosner, B., Colton, T., Hennekens, C. H. Randomised trials of arninoglycoside antibiotics: quantitative overview. Rev. Infect Dis. 1988: 10, 951–957.
Crifo, S., Antonelli, M., Gagliardi, M., Lucarelli, N., Marcolini, P. Ototoxicity of aminoglycoside antibiotics in long-tenn treatment of cystic fibrosis. Int J. Pediatr. Otorhinolalyngol. 1980: 2, 251–253.
Morgan, D. W., Pearman, K., Shenoi, P. M., Stableforth, D. Ototoxicity in adult cystic fibrosis: relationship to aminoglycoside blood levels, total dose, and duration of treatment. Thorax. 1988: 43, 236P.
Hjelte, L., Karlson, K., Gleisner, L., Strandvik, B. Hearing in relation to aminoglycoside dosage in cystic fibrosis. 10th International Cystic Fibrosis Congress, Sydney, Australia. Excerpta Medica, Hong Kong: 1988: 107.
Byrne, J. E., Kerr, A. G. Sensorineural hearing loss. In: Scott-Brown’s Otolaryngeal, Volume 3, Kerr, A. G., Groves, J. (eds.). Fifth edition. Butterworth and Co. (Publishers) Ltd., London. 1987: 381–386.
Diamond, C. Ear, nose and throat disorders. In: Textbook of adverse drug reactions, Davies, D. M. (ed.). Third edition. Oxford University Press. Oxford. 1085: 530–548.
Moffat, D. A. Ototoxicity. In: Scott-Brown’s Otolaryngeal, Volume 3, Kerr, A. G., Groves, J. (eds.). Fifth edition. Butterworth and Co. (Publishers) Ltd., London. 1987: 465–499.
Stupp, H., Kupper, F., Lagler, F., Sous, H., Quante, M. Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application. Audiology 1973: 12, 350–363.
Hawkins, J. E. Ototoxic mechanisms: a working hypothesis. Audiology 1973: 12, 383–393.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mulherin, D., Fahy, J., Grant, W. et al. Aminoglycoside induced ototoxicity in patients with cystic fibrosis. I.J.M.S. 160, 173–175 (1991). https://doi.org/10.1007/BF02961666
Issue Date:
DOI: https://doi.org/10.1007/BF02961666